UK begins trials of Ebola vaccine developed in just eight weeks

The UK medicines regulator has approved trials of an experimental Ebola vaccine on healthy adults. Developed by Oxford University in only eight weeks, the jab aims to combat the fast-spreading Bundibugyo strain. This medical intervention could be ready for deployment to the Democratic Republic of Congo within weeks. The trials represent a critical step in addressing the outbreak, focusing on rapid development to ensure the vaccine can be delivered to affected regions as quickly as possible.